Clinical trials
Phase 1/2 Anemia, Refractory, with Excess of Blasts trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 3 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| Fred Hutchinson Cancer Center | 4 |
| ARCE Therapeutics, Inc. | 1 |
| Case Comprehensive Cancer Center | 1 |
| Cellerant Therapeutics | 1 |
| Children's Hospital of Philadelphia | 1 |
| City of Hope Medical Center | 1 |
| Drexel University College of Medicine | 1 |
| Duke University | 1 |
| IGF Oncology, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 29 |
| Leukemia, Myeloid, Acute | 15 |
| Leukemia, Myelomonocytic, Chronic | 14 |
| Myelodysplastic Syndromes | 12 |
| Leukemia | 11 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Myeloproliferative Disorders | 8 |
| Hematologic Neoplasms | 5 |
| Anemia, Refractory | 4 |
| Blast Crisis | 4 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.